These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
173 related items for PubMed ID: 2526794
1. Complications of corticosteroid and immunosuppressive drugs. Rubin B, Palestine AG. Int Ophthalmol Clin; 1989; 29(3):159-71. PubMed ID: 2526794 [No Abstract] [Full Text] [Related]
2. Endocrine complications of topical and intralesional corticosteroid therapy. Curtis JA, Cormode E, Laski B, Toole J, Howard N. Arch Dis Child; 1982 Mar; 57(3):204-7. PubMed ID: 6462114 [Abstract] [Full Text] [Related]
3. Overview of the side effects of corticosteroid therapy. Ansell BM. Clin Exp Rheumatol; 1991 Mar; 9 Suppl 6():19-20. PubMed ID: 2060172 [No Abstract] [Full Text] [Related]
4. Uses, adverse effects of abuse of corticosteroids. Part II. Imam AP, Halpern GM. Allergol Immunopathol (Madr); 1995 Mar; 23(1):2-15. PubMed ID: 7631589 [No Abstract] [Full Text] [Related]
5. Inhaled corticosteroids--their present and future role in the management of asthma. König P. J Allergy Clin Immunol; 1988 Aug; 82(2):297-306. PubMed ID: 3042840 [No Abstract] [Full Text] [Related]
9. Oral vs parenteral corticosteroids: a clinical controversy. Rees RB. J Am Acad Dermatol; 1981 Nov 15; 5(5):602-4. PubMed ID: 7298927 [No Abstract] [Full Text] [Related]
10. Nephrotoxicities of antineoplastic and immunosuppressive agents. Raymond JR. Curr Probl Cancer; 1984 Oct 15; 8(16):1-32. PubMed ID: 6238806 [No Abstract] [Full Text] [Related]
12. Topical steroids and hypothalamo-pituitary-adrenal suppression: a review. Bartley PC. Australas J Dermatol; 1978 Dec 15; 19(3):109-13. PubMed ID: 371599 [No Abstract] [Full Text] [Related]
13. [Corticosteroid therapy in multiple sclerosis. Comment on the letter by M. Haupts et al]. Hohlfeld R, Engelhardt D. Nervenarzt; 1994 Feb 15; 65(2):148. PubMed ID: 8164771 [No Abstract] [Full Text] [Related]
14. [Corticosteroid treatment and adrenal regulatory system]. Goischke HK. ZFA (Stuttgart); 1978 Aug 10; 54(22):1129-33. PubMed ID: 685408 [No Abstract] [Full Text] [Related]
16. Adrenal suppression after short-term corticosteroid therapy. Wilson KS, Parker AC. Lancet; 1979 May 12; 1(8124):1030. PubMed ID: 86742 [No Abstract] [Full Text] [Related]
17. Cushing's Syndrome in a 6-month-old Boy: A Rare Side-effect due to Inadequate use of Topical Corticosteroids. Ciccone S, Marini R, Bizzarri C, El Hachem M, Cappa M. Acta Derm Venereol; 2016 Jan 12; 96(1):138-9. PubMed ID: 26038976 [No Abstract] [Full Text] [Related]
18. Effects of oral and inhaled corticosteroids on the hypothalamic-pituitary-adrenal axis. Lipworth BJ, Jackson CM. J Allergy Clin Immunol; 1999 Sep 12; 104(3 Pt 1):713-4. PubMed ID: 10482856 [No Abstract] [Full Text] [Related]
19. Locally administered ocular corticosteroids: benefits and risks. McGhee CN, Dean S, Danesh-Meyer H. Drug Saf; 2002 Sep 12; 25(1):33-55. PubMed ID: 11820911 [Abstract] [Full Text] [Related]
20. Safety and efficacy of inhaled corticosteroids (ICS) in children with asthma. Petrisko MA, Skoner JD, Skoner DP. J Asthma; 2008 Sep 12; 45 Suppl 1():1-9. PubMed ID: 19093279 [Abstract] [Full Text] [Related] Page: [Next] [New Search]